Search Results 291-300 of 11749 for Linaclotide

  1. Copanlisib (intravenous route) - Side effects & uses - Mayo Clinic

    Copanlisib injection is used to treat follicular lymphoma that has come back after treatment with at least two previous medicines that did not work well. This ...

  2. Elinzanetant (oral route) - Side effects & dosage - Mayo Clinic

    This medicine is available only with your doctor's prescription. This product is available in the following dosage forms: Capsule, Liquid Filled. Back to top ...

  3. Adrenal cancer - Doctors and departments - Mayo Clinic

    Learn about this rare cancer that begins in the adrenal glands. Find out about symptoms, diagnosis and treatment.

  4. Chemotherapy For Clinical Trials - Mayo Clinic Research

    The goal is to prove feasibility as well as safety of this approach. We will test adaptive therapy in 35 metastatic breast cancer patients diagnosed with ER+ ...

  5. Publications - Linda B. Baughn, Ph.D. - Mayo Clinic

    Maclachlan KH, Papadimitriou M, Blaney P, Baughn LB, Shekarkhand T, Poos AM, Ziccheddu B, Tang H, Yan H, Diamond B, Zhang Y, Cimera R, Dogan A, Gagler D, ...

  6. Hodgkin Clinical Trials

    RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of cancer cells by stopping them from dividing or killing them. After ...

  7. Prevention of Hepatic Encephalopathy With Mobile Application Based Lactulose Titration - Mayo Clinic

    The purpose of this study is to determine if a mobile application used to label stools according to the Bristol Stool Scale can safely assist subjects with ...

  8. Inflammatory bowel disease (IBD)

    Mayo Clinic has made important contributions to the treatment of IBD over the years, including pioneering ileoanal anastomosis (J-pouch surgery) and ...

  9. Cancer Treatment! Clinical Trials

    This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.

  10. T-cell receptor diversity may be key to treatment of follicular lymphoma, Mayo study finds

    “The presence of costimulatory receptors on the cell surface allows the immune system to better recognize and attack cancer cells,” says Dr. Yang. “We also ...